首页|期刊导航|磁共振成像|钆塞酸二钠增强MRI预测肝细胞癌微血管侵犯的研究进展

钆塞酸二钠增强MRI预测肝细胞癌微血管侵犯的研究进展OA

Research progress of gadoxetic acid disodium-enhanced MRI in predicting microvascular invasion of hepatocellular carcinoma

中文摘要英文摘要

肝细胞癌(hepatocellular carcinoma,HCC)是世界上常见的肿瘤之一,其治疗后复发率高,预后差.微血管侵犯(micro vascular invasion,MVI)作为HCC侵袭性生物学行为的核心标志,是影响HCC患者术后复发和生存的重要因素.目前,MVI诊断主要依靠术后病理活检,因有创及滞后,无法在术前为临床医生提供患者MVI风险等级的精准评估,进而无法指导术前新辅助治疗方案的制定,同时也不能为手术方式的选择及术中手术切缘的设定提供指导,无助于术前规划与术中决策.传统影像学检查(如CT、常规超声)对MVI的显示敏感度较低,钆塞酸二钠(gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid,GD-EOB-DTPA)作为肝细胞特异性对比剂,其影像征象可有效评估MVI风险,对于术前无创预测HCC MVI具有重要作用.在此基础上发展的人工智能技术为HCC术前MVI预测提供了新路径.本文突破既往综述"泛化覆盖多类影像学技术"的局限,以GD-EOB-DTPA增强MRI为核心主线,从GD-EOB-DTPA增强MRI影像征象及相关影像组学、生境成像和深度学习预测HCC MVI的研究现状展开综述,为HCC患者提供个性化治疗,为临床诊断和治疗提供参考.

Hepatocellular carcinoma(HCC)is one of the most common tumors worldwide,with a high recurrence rate and poor prognosis after treatment.Microvascular invasion(MVI),as a core marker of the aggressive biological behavior of HCC,is an important factor affecting the postoperative recurrence and survival of HCC patients.Currently,the diagnosis of MVI mainly relies on postoperative pathological biopsy,which is invasive and lagging,and cannot provide a precise assessment of the MVI risk level for patients before surgery for clinicians,thus failing to guide the formulation of preoperative neoadjuvant treatment plans.It also cannot provide guidance for the selection of surgical methods and the setting of surgical margins during the operation,and is of no help for preoperative planning and intraoperative decision-making.Traditional imaging examinations(such as CT and conventional ultrasound)have a low sensitivity in showing MVI.Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid(GD-EOB-DTPA),as a liver cell-specific contrast agent,its imaging signs can effectively evaluate the MVI risk and play an important role in non-invasive prediction of HCC MVI before surgery.On this basis,the development of artificial intelligence technology provides a new path for the preoperative prediction of MVI in HCC.This article breaks through the limitations of previous reviews that"generalize and cover multiple imaging techniques",and takes GD-EOB-DTPA-enhanced MRI as the main thread.This article will review the current research status of GD-EOB-DTPA enhanced MRI imaging signs and related radiomics,habitat imaging and deep learning in predicting HCC MVI,providing personalized treatment for HCC patients and references for clinical diagnosis and treatment.

陈智英;谭艳

山西医科大学医学影像学院,太原 030001山西医科大学第一医院影像科,太原 030001

医药卫生

肝细胞癌微血管侵犯钆塞酸二钠影像组学深度学习生境分析

hepatocellular carcinomamicrovascular invasionGD-EOB-DTPAradiomicsdeep learninghabitat analysis

《磁共振成像》 2026 (8)

206-211,225,7

National Natural Science Foundation of China(No.82371941). 国家自然科学基金项目(编号:82371941)

10.12015/issn.1674-8034.2026.08.024

评论